Neuroprotective Effects of Hypothermia Combined With Inhaled Xenon Following Perinatal Asphyxia
Condition(s):Hypoxic Ischaemic EncephalopathyLast Updated:April 21, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Hypoxic Ischaemic EncephalopathyLast Updated:April 21, 2022Completed
Condition(s):Idiopathic Pulmonary Fibrosis; Progressive Pulmonary FibrosisLast Updated:January 17, 2024Recruiting
Condition(s):AnesthesiaLast Updated:March 31, 2015Completed
Condition(s):Lung DiseaseLast Updated:May 15, 2023Recruiting
Condition(s):Hypoxic Ischaemic EncephalopathyLast Updated:January 5, 2023Completed
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:January 17, 2024Active, not recruiting
Condition(s):Efficacy and Safety of Xenon Inhalation; Successful Cardiopulmonary Resuscitation; Addition to Therapeutical HypothermiaLast Updated:September 23, 2015Terminated
Condition(s):Healthy VolunteersLast Updated:May 15, 2023Recruiting
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:November 4, 2020Recruiting
Condition(s):Hypoxic Ischaemic EncephalopathyLast Updated:December 15, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.